1Dominic RM, Shenoy S, Baliga S. Candida biofllms in medical devices: evolving trends. Kathmandu Up.iv Med J (KUMJ), 2007, 5(3): 431-436.
2Albuquerque P, Casadevall A. Quorum sensing in fungi-a review. Med Mycol, 2012, 50(4) : 337-345.
3Han TL, Cannon RD, Villas-Btlas SG. The metabolic response of Candida albicans to farnesol under hyphae-inducing conditions. FEMS Yeast Res, 2012, 12(8) : 879-889.
4Decanis N, Tazi N, Correia A, et al. Farnesol, a fungal quorum-sensing molecule triggers Candida albicans morphological changes by downregulating the expression of different secreted aapartyl pro- teinase genes. Open Micrebiol J, 2011,5: 119-126.
5Andes D, Nett J, Oschel P, et sl. Development and characterization of an in vivo central venous catheter Candida albicans biofilm model. Infect Immun, 2004, 72(10) : 6023-6031.
6Yang YH, Dudoit S, Luu P, et 81. Normalization for eDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res, 2002, 30 (4) : e15.
7Alem MA, Oteef MD, Flowers TH, et al. Production of tyrosol by Candida albicans biofilms and its role in quorum sensing and biofilm development. Eukaryot Cell, 2006, 5(10) : 1770-1779.
8Nickerson KW, Atldn AL, Hornby JM. Quorum sensing in dimorphic fungi: farnesol and beyond. Appl Environ Microbiol, 2006, 72(6) : 3805-3813.
9Zhang L, Chang W, Sun B, et al. Bisbibenzyls, a new type of antifungal agent, inhibit morphogenesis switch and biofilm formation through upregulation of DPP3 in Candida albicans. PLoS One, 2011, 6(12) : e28953.
10Kruppa M. Quorum sensing and Candida albicans. Mycoses, 2009, 52(1) : 1-10.
